Maravai LifeSciences Holdings Inc at Jefferies London Healthcare Conference Transcript
Good afternoon. Thanks for being here at the last session of our London conference. We're very excited to have Maravai LifeSciences with us today, here to tell us more about the story before we jump into some Q&A, CEO, Trey Martin; as well as CFO, Kevin Herde. Turn it over to Trey.
All right. Thank you. Thanks for being here in person. I know it sounds like we're at the tail end of this conference and also thanks to those who are joining us online. As with every other presentation you'll probably see today, we'll be making forward-looking statements using some non-GAAP terms such as adjusted EBITDA. And we have, of course, all of our risk factors listed in our SEC filings on the website.
All right. I thought I would start for this group with a little bit of the history of Maravai, where it came from and where it's going. So Maravai is almost a 10-year-old company. As of next March, that will be the 10-year anniversary.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |